nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—OPRK1—Progesterone—uterine cancer	0.362	0.507	CbGbCtD
Pethidine—CYP2C19—Progesterone—uterine cancer	0.0869	0.122	CbGbCtD
Pethidine—CYP2D6—Progesterone—uterine cancer	0.0661	0.0926	CbGbCtD
Pethidine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0634	0.0889	CbGbCtD
Pethidine—CYP3A4—Progesterone—uterine cancer	0.042	0.0589	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—uterine cancer	0.0418	0.0585	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—uterine cancer	0.0202	0.0283	CbGbCtD
Pethidine—CYP3A4—Etoposide—uterine cancer	0.0188	0.0264	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—uterine cancer	0.0128	0.018	CbGbCtD
Pethidine—Phlebitis—Carboplatin—uterine cancer	0.00505	0.0221	CcSEcCtD
Pethidine—Glutethimide—CYP11A1—uterine cancer	0.005	0.665	CrCbGaD
Pethidine—Myoclonus—Medroxyprogesterone Acetate—uterine cancer	0.00474	0.0208	CcSEcCtD
Pethidine—Paranoia—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.0183	CcSEcCtD
Pethidine—Neurotoxicity—Etoposide—uterine cancer	0.00415	0.0182	CcSEcCtD
Pethidine—Paralysis—Medroxyprogesterone Acetate—uterine cancer	0.0041	0.018	CcSEcCtD
Pethidine—Induration—Etoposide—uterine cancer	0.0036	0.0158	CcSEcCtD
Pethidine—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.00349	0.0153	CcSEcCtD
Pethidine—Depressed level of consciousness—Progesterone—uterine cancer	0.00304	0.0133	CcSEcCtD
Pethidine—Lightheadedness—Progesterone—uterine cancer	0.00281	0.0124	CcSEcCtD
Pethidine—Anuria—Epirubicin—uterine cancer	0.00258	0.0113	CcSEcCtD
Pethidine—Disorientation—Progesterone—uterine cancer	0.00255	0.0112	CcSEcCtD
Pethidine—Etomidate—CYP19A1—uterine cancer	0.00252	0.335	CrCbGaD
Pethidine—Libido decreased—Progesterone—uterine cancer	0.00246	0.0108	CcSEcCtD
Pethidine—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.0107	CcSEcCtD
Pethidine—Visual disturbance—Progesterone—uterine cancer	0.00241	0.0106	CcSEcCtD
Pethidine—Anuria—Doxorubicin—uterine cancer	0.00239	0.0105	CcSEcCtD
Pethidine—Neurotoxicity—Epirubicin—uterine cancer	0.00233	0.0102	CcSEcCtD
Pethidine—Disturbance in sexual arousal—Progesterone—uterine cancer	0.00227	0.00994	CcSEcCtD
Pethidine—Affect lability—Progesterone—uterine cancer	0.00225	0.00986	CcSEcCtD
Pethidine—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.00979	CcSEcCtD
Pethidine—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00218	0.00958	CcSEcCtD
Pethidine—Irritability—Progesterone—uterine cancer	0.00218	0.00956	CcSEcCtD
Pethidine—Mood swings—Progesterone—uterine cancer	0.00216	0.00949	CcSEcCtD
Pethidine—Neurotoxicity—Doxorubicin—uterine cancer	0.00215	0.00945	CcSEcCtD
Pethidine—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00901	CcSEcCtD
Pethidine—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00894	CcSEcCtD
Pethidine—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00887	CcSEcCtD
Pethidine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00867	CcSEcCtD
Pethidine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00863	CcSEcCtD
Pethidine—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.0086	CcSEcCtD
Pethidine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00829	CcSEcCtD
Pethidine—Phlebitis—Dactinomycin—uterine cancer	0.00187	0.00822	CcSEcCtD
Pethidine—Drowsiness—Progesterone—uterine cancer	0.00176	0.00772	CcSEcCtD
Pethidine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.007	CcSEcCtD
Pethidine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00671	CcSEcCtD
Pethidine—Visual impairment—Progesterone—uterine cancer	0.00152	0.00668	CcSEcCtD
Pethidine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00639	CcSEcCtD
Pethidine—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00605	CcSEcCtD
Pethidine—Erythema—Progesterone—uterine cancer	0.00138	0.00603	CcSEcCtD
Pethidine—Phlebitis—Etoposide—uterine cancer	0.00136	0.00595	CcSEcCtD
Pethidine—Muscle spasms—Progesterone—uterine cancer	0.00132	0.0058	CcSEcCtD
Pethidine—Paralysis—Epirubicin—uterine cancer	0.0013	0.0057	CcSEcCtD
Pethidine—Tremor—Progesterone—uterine cancer	0.00129	0.00565	CcSEcCtD
Pethidine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00547	CcSEcCtD
Pethidine—Vertigo—Progesterone—uterine cancer	0.00124	0.00542	CcSEcCtD
Pethidine—Syncope—Progesterone—uterine cancer	0.00123	0.00541	CcSEcCtD
Pethidine—Palpitations—Progesterone—uterine cancer	0.00122	0.00533	CcSEcCtD
Pethidine—Loss of consciousness—Progesterone—uterine cancer	0.00121	0.0053	CcSEcCtD
Pethidine—Paralysis—Doxorubicin—uterine cancer	0.0012	0.00527	CcSEcCtD
Pethidine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00526	CcSEcCtD
Pethidine—Convulsion—Progesterone—uterine cancer	0.00119	0.00523	CcSEcCtD
Pethidine—Hypertension—Progesterone—uterine cancer	0.00119	0.00521	CcSEcCtD
Pethidine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00512	CcSEcCtD
Pethidine—Anxiety—Progesterone—uterine cancer	0.00117	0.00512	CcSEcCtD
Pethidine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00502	CcSEcCtD
Pethidine—Dry mouth—Progesterone—uterine cancer	0.00114	0.00502	CcSEcCtD
Pethidine—Confusional state—Progesterone—uterine cancer	0.00113	0.00497	CcSEcCtD
Pethidine—Anaphylactic shock—Progesterone—uterine cancer	0.00112	0.00492	CcSEcCtD
Pethidine—Oedema—Progesterone—uterine cancer	0.00112	0.00492	CcSEcCtD
Pethidine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00491	CcSEcCtD
Pethidine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.0049	CcSEcCtD
Pethidine—Cardiac arrest—Etoposide—uterine cancer	0.00111	0.00487	CcSEcCtD
Pethidine—Injection site pain—Epirubicin—uterine cancer	0.0011	0.00485	CcSEcCtD
Pethidine—Shock—Progesterone—uterine cancer	0.0011	0.00485	CcSEcCtD
Pethidine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00483	CcSEcCtD
Pethidine—Tachycardia—Progesterone—uterine cancer	0.0011	0.00481	CcSEcCtD
Pethidine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00481	CcSEcCtD
Pethidine—Hyperhidrosis—Progesterone—uterine cancer	0.00108	0.00476	CcSEcCtD
Pethidine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00474	CcSEcCtD
Pethidine—Anorexia—Progesterone—uterine cancer	0.00107	0.00469	CcSEcCtD
Pethidine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00464	CcSEcCtD
Pethidine—Delirium—Epirubicin—uterine cancer	0.00105	0.0046	CcSEcCtD
Pethidine—Hypotension—Progesterone—uterine cancer	0.00105	0.0046	CcSEcCtD
Pethidine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00455	CcSEcCtD
Pethidine—Flushing—Dactinomycin—uterine cancer	0.00104	0.00455	CcSEcCtD
Pethidine—Vasodilation—Epirubicin—uterine cancer	0.00103	0.0045	CcSEcCtD
Pethidine—Vasodilation procedure—Epirubicin—uterine cancer	0.00103	0.0045	CcSEcCtD
Pethidine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.0045	CcSEcCtD
Pethidine—Injection site pain—Doxorubicin—uterine cancer	0.00102	0.00449	CcSEcCtD
Pethidine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00446	CcSEcCtD
Pethidine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00446	CcSEcCtD
Pethidine—Insomnia—Progesterone—uterine cancer	0.00102	0.00445	CcSEcCtD
Pethidine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00439	CcSEcCtD
Pethidine—Somnolence—Progesterone—uterine cancer	0.000998	0.00438	CcSEcCtD
Pethidine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000993	0.00436	CcSEcCtD
Pethidine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000983	0.00431	CcSEcCtD
Pethidine—Decreased appetite—Progesterone—uterine cancer	0.000976	0.00428	CcSEcCtD
Pethidine—Erythema—Dactinomycin—uterine cancer	0.000972	0.00426	CcSEcCtD
Pethidine—Delirium—Doxorubicin—uterine cancer	0.00097	0.00426	CcSEcCtD
Pethidine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000969	0.00425	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—uterine cancer	0.00096	0.00421	CcSEcCtD
Pethidine—Constipation—Progesterone—uterine cancer	0.00096	0.00421	CcSEcCtD
Pethidine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00095	0.00417	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—uterine cancer	0.00095	0.00417	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—uterine cancer	0.00095	0.00417	CcSEcCtD
Pethidine—Feeling abnormal—Progesterone—uterine cancer	0.000925	0.00406	CcSEcCtD
Pethidine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00092	0.00404	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—uterine cancer	0.000919	0.00403	CcSEcCtD
Pethidine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000904	0.00397	CcSEcCtD
Pethidine—Urticaria—Progesterone—uterine cancer	0.000892	0.00391	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—uterine cancer	0.000888	0.0039	CcSEcCtD
Pethidine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000884	0.00388	CcSEcCtD
Pethidine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00087	0.00382	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—uterine cancer	0.00085	0.00373	CcSEcCtD
Pethidine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.00368	CcSEcCtD
Pethidine—Hypersensitivity—Progesterone—uterine cancer	0.000827	0.00363	CcSEcCtD
Pethidine—Coma—Epirubicin—uterine cancer	0.000824	0.00362	CcSEcCtD
Pethidine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000808	0.00355	CcSEcCtD
Pethidine—Asthenia—Progesterone—uterine cancer	0.000805	0.00353	CcSEcCtD
Pethidine—Pruritus—Progesterone—uterine cancer	0.000794	0.00348	CcSEcCtD
Pethidine—Oedema—Dactinomycin—uterine cancer	0.000793	0.00348	CcSEcCtD
Pethidine—Coma—Doxorubicin—uterine cancer	0.000763	0.00335	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—uterine cancer	0.00076	0.00334	CcSEcCtD
Pethidine—Anorexia—Dactinomycin—uterine cancer	0.000756	0.00332	CcSEcCtD
Pethidine—Flushing—Etoposide—uterine cancer	0.00075	0.00329	CcSEcCtD
Pethidine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000749	0.00329	CcSEcCtD
Pethidine—Dizziness—Progesterone—uterine cancer	0.000742	0.00326	CcSEcCtD
Pethidine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00073	0.0032	CcSEcCtD
Pethidine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.00316	CcSEcCtD
Pethidine—Vomiting—Progesterone—uterine cancer	0.000714	0.00313	CcSEcCtD
Pethidine—Rash—Progesterone—uterine cancer	0.000708	0.00311	CcSEcCtD
Pethidine—Dermatitis—Progesterone—uterine cancer	0.000707	0.0031	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—uterine cancer	0.000703	0.00309	CcSEcCtD
Pethidine—Headache—Progesterone—uterine cancer	0.000703	0.00309	CcSEcCtD
Pethidine—Decreased appetite—Dactinomycin—uterine cancer	0.00069	0.00303	CcSEcCtD
Pethidine—Muscle spasms—Etoposide—uterine cancer	0.000676	0.00297	CcSEcCtD
Pethidine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000673	0.00295	CcSEcCtD
Pethidine—Nausea—Progesterone—uterine cancer	0.000667	0.00293	CcSEcCtD
Pethidine—Feeling abnormal—Dactinomycin—uterine cancer	0.000654	0.00287	CcSEcCtD
Pethidine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000647	0.00284	CcSEcCtD
Pethidine—Affect lability—Epirubicin—uterine cancer	0.000644	0.00283	CcSEcCtD
Pethidine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00281	CcSEcCtD
Pethidine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00281	CcSEcCtD
Pethidine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000637	0.0028	CcSEcCtD
Pethidine—Vertigo—Etoposide—uterine cancer	0.000632	0.00277	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—uterine cancer	0.000623	0.00273	CcSEcCtD
Pethidine—Mood swings—Epirubicin—uterine cancer	0.00062	0.00272	CcSEcCtD
Pethidine—Loss of consciousness—Etoposide—uterine cancer	0.000618	0.00271	CcSEcCtD
Pethidine—Convulsion—Etoposide—uterine cancer	0.000609	0.00267	CcSEcCtD
Pethidine—Hypertension—Etoposide—uterine cancer	0.000607	0.00267	CcSEcCtD
Pethidine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000604	0.00265	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000598	0.00262	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—uterine cancer	0.000596	0.00262	CcSEcCtD
Pethidine—Hypersensitivity—Dactinomycin—uterine cancer	0.000584	0.00256	CcSEcCtD
Pethidine—Confusional state—Etoposide—uterine cancer	0.000579	0.00254	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—uterine cancer	0.000576	0.00253	CcSEcCtD
Pethidine—Anaphylactic shock—Etoposide—uterine cancer	0.000574	0.00252	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—uterine cancer	0.000574	0.00252	CcSEcCtD
Pethidine—Asthenia—Dactinomycin—uterine cancer	0.000569	0.0025	CcSEcCtD
Pethidine—Tachycardia—Etoposide—uterine cancer	0.00056	0.00246	CcSEcCtD
Pethidine—Hyperhidrosis—Etoposide—uterine cancer	0.000555	0.00244	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000553	0.00243	CcSEcCtD
Pethidine—Anorexia—Etoposide—uterine cancer	0.000547	0.0024	CcSEcCtD
Pethidine—Hypotension—Etoposide—uterine cancer	0.000536	0.00235	CcSEcCtD
Pethidine—Somnolence—Etoposide—uterine cancer	0.00051	0.00224	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—uterine cancer	0.000505	0.00221	CcSEcCtD
Pethidine—Vomiting—Dactinomycin—uterine cancer	0.000504	0.00221	CcSEcCtD
Pethidine—Rash—Dactinomycin—uterine cancer	0.0005	0.00219	CcSEcCtD
Pethidine—Decreased appetite—Etoposide—uterine cancer	0.000499	0.00219	CcSEcCtD
Pethidine—Constipation—Etoposide—uterine cancer	0.000491	0.00215	CcSEcCtD
Pethidine—Sweating—Epirubicin—uterine cancer	0.000484	0.00212	CcSEcCtD
Pethidine—Feeling abnormal—Etoposide—uterine cancer	0.000473	0.00208	CcSEcCtD
Pethidine—Nausea—Dactinomycin—uterine cancer	0.000471	0.00207	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—uterine cancer	0.000467	0.00205	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—uterine cancer	0.000461	0.00202	CcSEcCtD
Pethidine—Urticaria—Etoposide—uterine cancer	0.000456	0.002	CcSEcCtD
Pethidine—Sweating—Doxorubicin—uterine cancer	0.000448	0.00196	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—uterine cancer	0.000437	0.00192	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—uterine cancer	0.000427	0.00187	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—uterine cancer	0.000423	0.00186	CcSEcCtD
Pethidine—Flushing—Epirubicin—uterine cancer	0.00042	0.00184	CcSEcCtD
Pethidine—Asthenia—Etoposide—uterine cancer	0.000412	0.00181	CcSEcCtD
Pethidine—Pruritus—Etoposide—uterine cancer	0.000406	0.00178	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—uterine cancer	0.000404	0.00177	CcSEcCtD
Pethidine—Erythema—Epirubicin—uterine cancer	0.000394	0.00173	CcSEcCtD
Pethidine—Flushing—Doxorubicin—uterine cancer	0.000389	0.00171	CcSEcCtD
Pethidine—Dizziness—Etoposide—uterine cancer	0.00038	0.00167	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—uterine cancer	0.000379	0.00166	CcSEcCtD
Pethidine—Vomiting—Etoposide—uterine cancer	0.000365	0.0016	CcSEcCtD
Pethidine—Erythema—Doxorubicin—uterine cancer	0.000365	0.0016	CcSEcCtD
Pethidine—Agitation—Epirubicin—uterine cancer	0.000362	0.00159	CcSEcCtD
Pethidine—Rash—Etoposide—uterine cancer	0.000362	0.00159	CcSEcCtD
Pethidine—Dermatitis—Etoposide—uterine cancer	0.000362	0.00159	CcSEcCtD
Pethidine—Headache—Etoposide—uterine cancer	0.00036	0.00158	CcSEcCtD
Pethidine—Vertigo—Epirubicin—uterine cancer	0.000354	0.00155	CcSEcCtD
Pethidine—Syncope—Epirubicin—uterine cancer	0.000354	0.00155	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—uterine cancer	0.000351	0.00154	CcSEcCtD
Pethidine—Palpitations—Epirubicin—uterine cancer	0.000348	0.00153	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—uterine cancer	0.000347	0.00152	CcSEcCtD
Pethidine—Convulsion—Epirubicin—uterine cancer	0.000342	0.0015	CcSEcCtD
Pethidine—Nausea—Etoposide—uterine cancer	0.000341	0.0015	CcSEcCtD
Pethidine—Hypertension—Epirubicin—uterine cancer	0.00034	0.00149	CcSEcCtD
Pethidine—Agitation—Doxorubicin—uterine cancer	0.000335	0.00147	CcSEcCtD
Pethidine—Anxiety—Epirubicin—uterine cancer	0.000335	0.00147	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—uterine cancer	0.000328	0.00144	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—uterine cancer	0.000328	0.00144	CcSEcCtD
Pethidine—Syncope—Doxorubicin—uterine cancer	0.000327	0.00144	CcSEcCtD
Pethidine—Confusional state—Epirubicin—uterine cancer	0.000324	0.00142	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—uterine cancer	0.000322	0.00141	CcSEcCtD
Pethidine—Oedema—Epirubicin—uterine cancer	0.000322	0.00141	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—uterine cancer	0.000322	0.00141	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—uterine cancer	0.000321	0.00141	CcSEcCtD
Pethidine—Shock—Epirubicin—uterine cancer	0.000317	0.00139	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—uterine cancer	0.000316	0.00139	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—uterine cancer	0.000315	0.00138	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—uterine cancer	0.000314	0.00138	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—uterine cancer	0.000311	0.00137	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—uterine cancer	0.00031	0.00136	CcSEcCtD
Pethidine—Anorexia—Epirubicin—uterine cancer	0.000307	0.00135	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—uterine cancer	0.000304	0.00133	CcSEcCtD
Pethidine—Hypotension—Epirubicin—uterine cancer	0.000301	0.00132	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—uterine cancer	0.0003	0.00132	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000298	0.00131	CcSEcCtD
Pethidine—Oedema—Doxorubicin—uterine cancer	0.000298	0.00131	CcSEcCtD
Pethidine—Shock—Doxorubicin—uterine cancer	0.000293	0.00129	CcSEcCtD
Pethidine—Insomnia—Epirubicin—uterine cancer	0.000291	0.00128	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—uterine cancer	0.000291	0.00128	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000288	0.00126	CcSEcCtD
Pethidine—Somnolence—Epirubicin—uterine cancer	0.000286	0.00126	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—uterine cancer	0.000284	0.00125	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—uterine cancer	0.00028	0.00123	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—uterine cancer	0.000278	0.00122	CcSEcCtD
Pethidine—Constipation—Epirubicin—uterine cancer	0.000275	0.00121	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—uterine cancer	0.000269	0.00118	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—uterine cancer	0.000265	0.00116	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—uterine cancer	0.000265	0.00116	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—uterine cancer	0.000259	0.00114	CcSEcCtD
Pethidine—Urticaria—Epirubicin—uterine cancer	0.000256	0.00112	CcSEcCtD
Pethidine—Constipation—Doxorubicin—uterine cancer	0.000255	0.00112	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—uterine cancer	0.000245	0.00108	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—uterine cancer	0.000237	0.00104	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—uterine cancer	0.000237	0.00104	CcSEcCtD
Pethidine—Asthenia—Epirubicin—uterine cancer	0.000231	0.00101	CcSEcCtD
Pethidine—Pruritus—Epirubicin—uterine cancer	0.000228	0.000999	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—uterine cancer	0.000219	0.000963	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—uterine cancer	0.000214	0.000937	CcSEcCtD
Pethidine—Dizziness—Epirubicin—uterine cancer	0.000213	0.000934	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—uterine cancer	0.000211	0.000924	CcSEcCtD
Pethidine—Vomiting—Epirubicin—uterine cancer	0.000205	0.000898	CcSEcCtD
Pethidine—Rash—Epirubicin—uterine cancer	0.000203	0.00089	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—uterine cancer	0.000203	0.00089	CcSEcCtD
Pethidine—Headache—Epirubicin—uterine cancer	0.000202	0.000885	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—uterine cancer	0.000197	0.000864	CcSEcCtD
Pethidine—Nausea—Epirubicin—uterine cancer	0.000191	0.000839	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—uterine cancer	0.000189	0.000831	CcSEcCtD
Pethidine—Rash—Doxorubicin—uterine cancer	0.000188	0.000824	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—uterine cancer	0.000188	0.000823	CcSEcCtD
Pethidine—Headache—Doxorubicin—uterine cancer	0.000187	0.000819	CcSEcCtD
Pethidine—Nausea—Doxorubicin—uterine cancer	0.000177	0.000776	CcSEcCtD
Pethidine—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.81e-05	0.00134	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	6.78e-05	0.00133	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—EP300—uterine cancer	6.69e-05	0.00132	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	6.69e-05	0.00132	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	6.61e-05	0.0013	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CXCL8—uterine cancer	6.58e-05	0.0013	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CXCL8—uterine cancer	6.57e-05	0.00129	CbGpPWpGaD
Pethidine—GRIN2D—Neuronal System—HRAS—uterine cancer	6.55e-05	0.00129	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.43e-05	0.00127	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.43e-05	0.00127	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.4e-05	0.00126	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKR1B10—uterine cancer	6.34e-05	0.00125	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—AKT1—uterine cancer	6.2e-05	0.00122	CbGpPWpGaD
Pethidine—GRIN1—Transmission across Chemical Synapses—HRAS—uterine cancer	6.13e-05	0.00121	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	6.02e-05	0.00119	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—HRAS—uterine cancer	5.97e-05	0.00118	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.94e-05	0.00117	CbGpPWpGaD
Pethidine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	5.89e-05	0.00116	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—VEGFA—uterine cancer	5.76e-05	0.00113	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—VEGFA—uterine cancer	5.72e-05	0.00113	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—NRAS—uterine cancer	5.69e-05	0.00112	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—VEGFA—uterine cancer	5.62e-05	0.00111	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.61e-05	0.0011	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	5.59e-05	0.0011	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CXCL8—uterine cancer	5.55e-05	0.00109	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—NRAS—uterine cancer	5.55e-05	0.00109	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	5.45e-05	0.00107	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—HRAS—uterine cancer	5.38e-05	0.00106	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKR1B10—uterine cancer	5.36e-05	0.00105	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—ERBB2—uterine cancer	5.34e-05	0.00105	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.26e-05	0.00104	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RNF43—uterine cancer	5.25e-05	0.00103	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SRD5A2—uterine cancer	5.24e-05	0.00103	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NDUFB11—uterine cancer	5.24e-05	0.00103	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	5.22e-05	0.00103	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—ERBB2—uterine cancer	5.2e-05	0.00102	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TP53—uterine cancer	5.04e-05	0.000992	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCL2—uterine cancer	5.03e-05	0.000991	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—KRAS—uterine cancer	4.9e-05	0.000965	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—INHBA—uterine cancer	4.8e-05	0.000946	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—TP53—uterine cancer	4.78e-05	0.000942	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—KRAS—uterine cancer	4.78e-05	0.00094	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.72e-05	0.000929	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—HRAS—uterine cancer	4.69e-05	0.000924	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CTNNB1—uterine cancer	4.67e-05	0.00092	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—HRAS—uterine cancer	4.58e-05	0.000901	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—CTNNB1—uterine cancer	4.55e-05	0.000897	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RNF43—uterine cancer	4.44e-05	0.000874	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.43e-05	0.000873	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IRF1—uterine cancer	4.42e-05	0.000871	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	4.42e-05	0.000869	CbGpPWpGaD
Pethidine—ALB—Metabolism—NDUFB11—uterine cancer	4.41e-05	0.000869	CbGpPWpGaD
Pethidine—ALB—Metabolism—SRD5A2—uterine cancer	4.41e-05	0.000869	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.37e-05	0.000861	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—EP300—uterine cancer	4.34e-05	0.000855	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKR1C1—uterine cancer	4.33e-05	0.000852	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.29e-05	0.000844	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCL2—uterine cancer	4.25e-05	0.000837	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—EP300—uterine cancer	4.23e-05	0.000833	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—HRAS—uterine cancer	4.16e-05	0.00082	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—VEGFA—uterine cancer	4.11e-05	0.00081	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—NRAS—uterine cancer	4.06e-05	0.0008	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—INHBA—uterine cancer	4.06e-05	0.0008	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—HRAS—uterine cancer	4.06e-05	0.000799	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.05e-05	0.000797	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—VEGFA—uterine cancer	4.01e-05	0.000789	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCL8—uterine cancer	3.98e-05	0.000783	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.96e-05	0.00078	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.96e-05	0.00078	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—NRAS—uterine cancer	3.96e-05	0.00078	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.85e-05	0.000757	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKR1B1—uterine cancer	3.79e-05	0.000746	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—STAR—uterine cancer	3.79e-05	0.000746	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKR1C1—uterine cancer	3.66e-05	0.00072	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SRD5A2—uterine cancer	3.64e-05	0.000717	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NDUFB11—uterine cancer	3.64e-05	0.000717	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.63e-05	0.000715	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—HRAS—uterine cancer	3.5e-05	0.000689	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—KRAS—uterine cancer	3.5e-05	0.000688	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—KRAS—uterine cancer	3.41e-05	0.000671	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCL8—uterine cancer	3.36e-05	0.000662	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKR1C3—uterine cancer	3.33e-05	0.000656	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PGR—uterine cancer	3.25e-05	0.000639	CbGpPWpGaD
Pethidine—ALB—Metabolism—STAR—uterine cancer	3.19e-05	0.000628	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKR1B1—uterine cancer	3.19e-05	0.000628	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.15e-05	0.000621	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—YWHAE—uterine cancer	3.1e-05	0.00061	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—POLD1—uterine cancer	2.97e-05	0.000585	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—HRAS—uterine cancer	2.97e-05	0.000585	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FBXW7—uterine cancer	2.97e-05	0.000584	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—HRAS—uterine cancer	2.9e-05	0.00057	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—STAR—uterine cancer	2.86e-05	0.000564	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.86e-05	0.000564	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.83e-05	0.000557	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKR1C3—uterine cancer	2.81e-05	0.000554	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.78e-05	0.000548	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PGR—uterine cancer	2.74e-05	0.00054	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—HRAS—uterine cancer	2.68e-05	0.000528	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.63e-05	0.000519	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—STAR—uterine cancer	2.63e-05	0.000519	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—AKT1—uterine cancer	2.62e-05	0.000517	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—YWHAE—uterine cancer	2.62e-05	0.000515	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STK11—uterine cancer	2.59e-05	0.000511	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCL2—uterine cancer	2.58e-05	0.000508	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—AKT1—uterine cancer	2.56e-05	0.000504	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	2.54e-05	0.000499	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FBXW7—uterine cancer	2.51e-05	0.000494	CbGpPWpGaD
Pethidine—ALB—Metabolism—POLD1—uterine cancer	2.5e-05	0.000493	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—RRM2—uterine cancer	2.48e-05	0.000488	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SOCS3—uterine cancer	2.43e-05	0.000478	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—DCN—uterine cancer	2.41e-05	0.000474	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.38e-05	0.000469	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.38e-05	0.000469	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKR1C1—uterine cancer	2.34e-05	0.000461	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN2B—uterine cancer	2.33e-05	0.000458	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP11A1—uterine cancer	2.27e-05	0.000446	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1R—uterine cancer	2.26e-05	0.000445	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL8—uterine cancer	2.25e-05	0.000443	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—POLD1—uterine cancer	2.25e-05	0.000442	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STK11—uterine cancer	2.19e-05	0.000432	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCL2—uterine cancer	2.18e-05	0.00043	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKR1C3—uterine cancer	2.14e-05	0.000422	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SMAD3—uterine cancer	2.12e-05	0.000418	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.1e-05	0.000414	CbGpPWpGaD
Pethidine—ALB—Metabolism—RRM2—uterine cancer	2.09e-05	0.000411	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—POLD1—uterine cancer	2.07e-05	0.000407	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SOCS3—uterine cancer	2.05e-05	0.000404	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—uterine cancer	2.04e-05	0.000402	CbGpPWpGaD
Pethidine—ALB—Metabolism—DCN—uterine cancer	2.03e-05	0.000399	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGFR2—uterine cancer	2.03e-05	0.000399	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.98e-05	0.00039	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN2B—uterine cancer	1.97e-05	0.000387	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.93e-05	0.000381	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1R—uterine cancer	1.91e-05	0.000376	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP11A1—uterine cancer	1.91e-05	0.000376	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—uterine cancer	1.9e-05	0.000374	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—RRM2—uterine cancer	1.87e-05	0.000369	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—DCN—uterine cancer	1.82e-05	0.000358	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKR1C3—uterine cancer	1.8e-05	0.000355	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SMAD3—uterine cancer	1.79e-05	0.000353	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ESR1—uterine cancer	1.73e-05	0.000341	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—uterine cancer	1.73e-05	0.00034	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—RRM2—uterine cancer	1.72e-05	0.000339	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.72e-05	0.000339	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—STAR—uterine cancer	1.72e-05	0.000339	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.71e-05	0.000337	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGFR2—uterine cancer	1.71e-05	0.000337	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—DCN—uterine cancer	1.67e-05	0.000329	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—STK11—uterine cancer	1.67e-05	0.000328	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.67e-05	0.000328	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—uterine cancer	1.64e-05	0.000323	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.62e-05	0.000319	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.62e-05	0.000319	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.58e-05	0.00031	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL2—uterine cancer	1.53e-05	0.0003	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.49e-05	0.000293	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ESR1—uterine cancer	1.46e-05	0.000288	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—uterine cancer	1.43e-05	0.000281	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—uterine cancer	1.41e-05	0.000278	CbGpPWpGaD
Pethidine—ALB—Metabolism—STK11—uterine cancer	1.4e-05	0.000276	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP19A1—uterine cancer	1.4e-05	0.000276	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—uterine cancer	1.38e-05	0.000273	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EP300—uterine cancer	1.38e-05	0.000272	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—POLD1—uterine cancer	1.35e-05	0.000266	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.32e-05	0.00026	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—uterine cancer	1.31e-05	0.000257	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—uterine cancer	1.3e-05	0.000255	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—uterine cancer	1.29e-05	0.000254	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL2—uterine cancer	1.29e-05	0.000254	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—uterine cancer	1.27e-05	0.00025	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.000249	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—STK11—uterine cancer	1.26e-05	0.000248	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.26e-05	0.000248	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.26e-05	0.000247	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—uterine cancer	1.25e-05	0.000247	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—uterine cancer	1.21e-05	0.000237	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—uterine cancer	1.21e-05	0.000237	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—uterine cancer	1.2e-05	0.000236	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—uterine cancer	1.19e-05	0.000235	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.18e-05	0.000233	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—uterine cancer	1.18e-05	0.000232	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—uterine cancer	1.17e-05	0.000229	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—STK11—uterine cancer	1.16e-05	0.000228	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.000228	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.13e-05	0.000222	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—RRM2—uterine cancer	1.13e-05	0.000222	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—uterine cancer	1.11e-05	0.000219	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—uterine cancer	1.11e-05	0.000219	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—uterine cancer	1.09e-05	0.000216	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—DCN—uterine cancer	1.09e-05	0.000215	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—uterine cancer	1.08e-05	0.000214	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—uterine cancer	1.07e-05	0.000212	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—uterine cancer	1.06e-05	0.000208	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—uterine cancer	1.06e-05	0.000208	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EP300—uterine cancer	1.03e-05	0.000204	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000203	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—uterine cancer	1.02e-05	0.000201	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—uterine cancer	1.02e-05	0.000201	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—uterine cancer	1.01e-05	0.000199	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—uterine cancer	9.96e-06	0.000196	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—uterine cancer	9.88e-06	0.000195	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—uterine cancer	9.85e-06	0.000194	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—uterine cancer	9.8e-06	0.000193	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKR1C3—uterine cancer	9.73e-06	0.000192	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—uterine cancer	9.68e-06	0.000191	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—uterine cancer	9.47e-06	0.000186	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—uterine cancer	9.45e-06	0.000186	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—uterine cancer	9.4e-06	0.000185	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.3e-06	0.000183	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—uterine cancer	9.17e-06	0.00018	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—uterine cancer	8.94e-06	0.000176	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EP300—uterine cancer	8.74e-06	0.000172	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—uterine cancer	8.71e-06	0.000172	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.35e-06	0.000164	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—uterine cancer	8.34e-06	0.000164	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—uterine cancer	8.33e-06	0.000164	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—uterine cancer	8.28e-06	0.000163	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—uterine cancer	8.18e-06	0.000161	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	7.65e-06	0.000151	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—STK11—uterine cancer	7.58e-06	0.000149	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.58e-06	0.000149	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—uterine cancer	7.4e-06	0.000146	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—uterine cancer	7.08e-06	0.000139	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—uterine cancer	7.04e-06	0.000139	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—uterine cancer	6.97e-06	0.000137	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—EP300—uterine cancer	6.65e-06	0.000131	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—uterine cancer	6.47e-06	0.000127	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—uterine cancer	6.26e-06	0.000123	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—uterine cancer	6.25e-06	0.000123	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—uterine cancer	5.98e-06	0.000118	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—uterine cancer	5.87e-06	0.000116	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—uterine cancer	5.7e-06	0.000112	CbGpPWpGaD
Pethidine—ALB—Metabolism—EP300—uterine cancer	5.6e-06	0.00011	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—uterine cancer	5.28e-06	0.000104	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—uterine cancer	5.27e-06	0.000104	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—EP300—uterine cancer	5.02e-06	9.89e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—uterine cancer	4.92e-06	9.69e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—uterine cancer	4.85e-06	9.54e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—EP300—uterine cancer	4.62e-06	9.1e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—uterine cancer	4.14e-06	8.15e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—uterine cancer	4.02e-06	7.91e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—uterine cancer	3.72e-06	7.32e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—uterine cancer	3.42e-06	6.73e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—uterine cancer	3.38e-06	6.66e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—uterine cancer	3.17e-06	6.24e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—uterine cancer	3.04e-06	5.98e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—EP300—uterine cancer	3.02e-06	5.95e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—uterine cancer	2.79e-06	5.5e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.24e-06	4.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—uterine cancer	1.83e-06	3.6e-05	CbGpPWpGaD
